Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Jade Biosciences, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 120
- +16 vs. Q4 2025
- Shares held
- 49.8M
- +4.87M (+10.8%) vs. Q4 2025
- Total value
- $700.3M
- +$6.37M (+0.9%) vs. Q4 2025
- New holders
- 29
- 38 more added
- Sold out
- 13
- 33 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 655,690 | $9.21M | 0.00% | +12,769+2.0% | Added |
| Acorn Capital Advisors, LLC | 786,760 | $11.1M | 3.14% | +786,760 | New |
| Soleus Capital Management, L.P. | 796,744 | $11.2M | 0.45% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 822,520 | $11.6M | 0.00% | −19,288−2.3% | Reduced |
| Standard Life Aberdeen plc | 867,284 | $12.2M | 0.02% | 00.0% | Unchanged |
| Marshall Wace, LLP | 944,776 | $13.3M | 0.01% | +69,503+7.9% | Added |
| Great Point Partners LLC | 964,462 | $13.6M | 3.32% | +158,189+19.6% | Added |
| Samsara BioCapital, LLC | 968,798 | $13.6M | 1.32% | 00.0% | Unchanged |
| Avidity Partners Management LP | 1,400,708 | $19.7M | 3.99% | 00.0% | Unchanged |
| Versant Venture Management, LLC | 1,525,820 | $21.4M | 15.16% | 00.0% | Unchanged |
| Remedium Capital Partners, LLC | 1,577,750 | $22.2M | 7.88% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 1,641,137 | $23.1M | 0.13% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 1,796,652 | $25.2M | 0.00% | +1,796,652 | New |
| BlackRock, Inc. | 2,313,949 | $32.5M | 0.00% | −556,364−19.4% | Reduced |
| Janus Henderson Group PLC | 3,105,669 | $43.6M | 0.02% | +3,105,669 | New |
| VR Adviser, LLC | 3,220,364 | $45.2M | 1.69% | 00.0% | Unchanged |
| Bellevue Group AG | 3,501,502 | $49.2M | 1.17% | +160,399+4.8% | Added |
| Ra Capital Management, L.P. | 3,671,083 | $51.6M | 0.55% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 4,553,494 | $64.0M | 4.62% | 00.0% | Unchanged |
| FMR LLC | 7,085,423 | $99.6M | 0.01% | +190,935+2.8% | Added |
| Caption Management, LLC | 0 | $0 | 0.00% | −297,095−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −187,254−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −82,056−100.0% | Sold out |
| 9823 Capital, L.P. | 0 | $0 | 0.00% | −53,191−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −24,200−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −14,012−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −21,570−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −12,469−100.0% | Sold out |
| Intech Investment Management LLC | 0 | $0 | 0.00% | −11,802−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,454−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| Torren Management, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |